ReviewEndocrine, metabolic & immune disorders drug targets2025

Mendelian Randomization Studies: Opening a New Window in the Study of Metabolic Diseases and Chronic Kidney Disease.

Ning Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.